These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15919001)

  • 21. Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.
    Chuang SY; Lee SC; Hsieh YT; Pan WH
    Asia Pac J Clin Nutr; 2011; 20(2):301-8. PubMed ID: 21669599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].
    Sellin L; Kielstein JT; de Groot K
    Z Rheumatol; 2015 May; 74(4):322-8. PubMed ID: 25962453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prescription for lifestyle change in patients with hyperuricemia and gout.
    Choi HK
    Curr Opin Rheumatol; 2010 Mar; 22(2):165-72. PubMed ID: 20035225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gout and hyperuricemia.
    Wortmann RL
    Curr Opin Rheumatol; 2002 May; 14(3):281-6. PubMed ID: 11981327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the epidemiology and genetics of gout.
    Zaka R; Williams CJ
    Curr Rheumatol Rep; 2006 Jun; 8(3):215-23. PubMed ID: 16901080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The changing epidemiology of gout.
    Roddy E; Zhang W; Doherty M
    Nat Clin Pract Rheumatol; 2007 Aug; 3(8):443-9. PubMed ID: 17664951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology, incidence and sex specific differences in primary gout].
    Peichl P
    Wien Med Wochenschr; 1997; 147(16):370-2. PubMed ID: 9446413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen.
    Lin KC; Lin HY; Chou P
    J Rheumatol; 2000 Apr; 27(4):1045-50. PubMed ID: 10782835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into gout epidemiology.
    Mikuls TR; Saag KG
    Curr Opin Rheumatol; 2006 Mar; 18(2):199-203. PubMed ID: 16462529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gout and comorbidities associated with hyperuricemia].
    Majdan M; Borys O
    Ann Acad Med Stetin; 2010; 56 Suppl 1():34-9. PubMed ID: 21365938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008.
    Zhu Y; Pandya BJ; Choi HK
    Am J Med; 2012 Jul; 125(7):679-687.e1. PubMed ID: 22626509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review.
    Li R; Yu K; Li C
    Asia Pac J Clin Nutr; 2018; 27(6):1344-1356. PubMed ID: 30485934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A literature review of the epidemiology and treatment of acute gout.
    Kim KY; Ralph Schumacher H; Hunsche E; Wertheimer AI; Kong SX
    Clin Ther; 2003 Jun; 25(6):1593-617. PubMed ID: 12860487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of crystal arthropathy.
    Choi H
    Rheum Dis Clin North Am; 2006 May; 32(2):255-73, v. PubMed ID: 16716879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperuricemia and Gout].
    Delbarba E; Terlizzi V; Dallera N; Izzi C; Scolari F
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle and dietary habits of patients with gout followed in rheumatology settings.
    Manara M; Carrara G; Scirè CA; Cimmino MA; Govoni M; Montecucco C; Matucci-Cerinic M; Minisola G; Study Group TK
    Reumatismo; 2015 Dec; 67(4):138-48. PubMed ID: 27215179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gout: a review of nonmodifiable and modifiable risk factors.
    MacFarlane LA; Kim SC
    Rheum Dis Clin North Am; 2014 Nov; 40(4):581-604. PubMed ID: 25437279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kidney in hyperuricemia and gout.
    Mount DB
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for gout and prevention: a systematic review of the literature.
    Singh JA; Reddy SG; Kundukulam J
    Curr Opin Rheumatol; 2011 Mar; 23(2):192-202. PubMed ID: 21285714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.